RU96118559A - MEDICINE - Google Patents

MEDICINE

Info

Publication number
RU96118559A
RU96118559A RU96118559/14A RU96118559A RU96118559A RU 96118559 A RU96118559 A RU 96118559A RU 96118559/14 A RU96118559/14 A RU 96118559/14A RU 96118559 A RU96118559 A RU 96118559A RU 96118559 A RU96118559 A RU 96118559A
Authority
RU
Russia
Prior art keywords
medicine
helepin
biologically active
active component
polyglucin
Prior art date
Application number
RU96118559/14A
Other languages
Russian (ru)
Other versions
RU2120294C1 (en
Inventor
С.А. Вичканова
Л.Д. Шипулина
В.И. Глызин
Ю.Ф. Майчук
Л.Е. Орловская
Л.П. Смирнова
Г.И. Климахин
Original Assignee
Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений"
Filing date
Publication date
Application filed by Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" filed Critical Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений"
Priority to RU96118559A priority Critical patent/RU2120294C1/en
Priority claimed from RU96118559A external-priority patent/RU2120294C1/en
Application granted granted Critical
Publication of RU2120294C1 publication Critical patent/RU2120294C1/en
Publication of RU96118559A publication Critical patent/RU96118559A/en

Links

Claims (1)

Средство для лечения офтальмогерпеса и аденовирусных заболеваний глаз на основе биологически активного компонента, отличающееся тем, что в качестве биологически активного компонента используют 0,2%-ный раствор хелепина Д на полиглюкине 6% в сочетании с таблетками хелепина Д.A tool for the treatment of ophthalmic herpes and adenoviral eye diseases based on a biologically active component, characterized in that a 0.2% solution of helepin D on polyglucin 6% in combination with tablets of helepin D. is used as a biologically active component.
RU96118559A 1996-09-17 1996-09-17 Drug RU2120294C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96118559A RU2120294C1 (en) 1996-09-17 1996-09-17 Drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96118559A RU2120294C1 (en) 1996-09-17 1996-09-17 Drug

Publications (2)

Publication Number Publication Date
RU2120294C1 RU2120294C1 (en) 1998-10-20
RU96118559A true RU96118559A (en) 1999-01-10

Family

ID=20185517

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96118559A RU2120294C1 (en) 1996-09-17 1996-09-17 Drug

Country Status (1)

Country Link
RU (1) RU2120294C1 (en)

Similar Documents

Publication Publication Date Title
CA2264895A1 (en) Device and method for treating ophthalmic diseases
CA2195213A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
AU8060394A (en) Ophthalmic formulation useful in the treatment of dry eye syndrom
IE791235L (en) Acyl-derivatives of carnitine.
ITRM930291A0 (en) PROCEDURE FOR THE PREPARATION OF IODINATED BIOPOLYMERS WITH DISINFECTANT AND HEALING ACTIVITY, AND IODINATED BIOPOLYMERS SO OBTAINED.
CA2130762A1 (en) Treatment of Disease and Conditions Associated with Macrophage Infiltration
CA2091134A1 (en) Therapeutic agent for threatened abortion
RU94011321A (en) METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES
RU96118559A (en) MEDICINE
DE69100171D1 (en) SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
FR2684552B1 (en) USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.
PT711163E (en) USE OF BENZIDAMINE IN THE TREATMENT OF TNF-INDUCED PATHOLOGICAL STATES
CA2197176A1 (en) Use of selegiline for the treatment of epileptic disorders
FR2702149B1 (en) Application of lamotrigine in the treatment of neuro-AIDS.
FI953622A (en) Use of ifenprodil and its diastereoisomers in the manufacture of a medicament useful in the treatment of peripheral neuropathic conditions and degenerative diseases of the central nervous system
HU9500120D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
GB9209599D0 (en) Novel therapy for the treatment of parkinsons disease
FR2709964B1 (en) Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes.
RU94005179A (en) MEANS FOR THE TREATMENT OF PATIENTS WITH FETAL SCLENODERMIA
FR2702151B1 (en) Application of anti-convulsants in the treatment of neuro-AIDS.
CA2309653A1 (en) Use of protein h as cytostatic agent
FR2697753B3 (en) Ophthalmic composition intended for the treatment of dry eyes, the maintenance of contact lenses and for use as an eyewash excipient.
RU96110609A (en) METHOD FOR TREATING POST-TRAUMATIC INNER-EYE INFECTION